Jones, A. B., Tuy, K., Hawkins, C. C., Quinn, C. H., Saad, J., Gary, S. E., . . . Hjelmeland, A. B. (2024). Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma. Cancers, 16(16), 2852-2864. https://doi.org/10.3390/cancers16162852

Jones, Amber B., et al. "Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma." Cancers 16, no. 16 (2024): 2852-2864. https://doi.org/10.3390/cancers16162852.

Jones, Amber B., et al. "Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma." Cancers, vol. 16, no. 16, 2024, pp. 2852-2864, https://doi.org/10.3390/cancers16162852.